LYSOSOMAL PROTEOLYSIS IN HEMATOPOIETIC CELLS
造血细胞中的溶酶体蛋白水解
基本信息
- 批准号:6381219
- 负责人:
- 金额:$ 27.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-17 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Investigator's abstract) Proteolysis is a fundamental
mechanism in all living organisms that provides a sensitive way for
titrating levels of active proteins essential for maintaining homeostasis
and diverse critical cellular functions. The molecular components of the
proteolytic machinery are incompletely understood. The central goal of this
proposal is to achieve a better understanding of the intricacies of this
machinery through the investigation of a novel lysosomal membrane protein
named LAPTm5. In murine animals, LAPTm5 is specifically expressed in
hematopoietic cells, and in human, it is preferentially expressed at high
levels in hematopoietic cells. The protein was found to bind to ubiquinated
proteins. There is accumulating evidence that ubiquination of proteins is
an important signal for proteolysis in lysosomes. LAPTm5 has also been
found to alter the level of IkB in lysosomes. IkBs are the key regulators
of the activation of NF-kB, a major transcriptional factor responsible for
regulating an extensive list of important genes including those involved in
immune and inflammatory response, cell adhesion, stress response
proliferation and differentiation. The process by which IkB is degraded and
regulated is therefore an area of intensive research. The immediate goal of
this proposal is to investigate the function of LAPTm5 from several
approaches indicated by these findings. Aim 1 will determine if LAPTm5 can
affect the NF-kB system by analyzing if it regulates IkB degradation in
lysosomes, whether it can activate NF-kB and whether it has an influence on
the responsiveness of the NF-kB system. Aim 2 will examine the role of
LAPTm5 in hematopoietic cell development by using the model of in vitro
differentiation of murine embryonal stem cells into hematopoietic cells.
The effect of a constitutive expression of the gene and a disruption of the
gene by homologous recombination will be analyzed. Aim 3 will use protein
chemistry techniques, including 2-D gel analysis to determine the identity
of the ubiquinated proteins that bind with LAPTm5. A direct in situ binding
assay with purified lysosomes will also be used to identify binding
proteins. New findings about this unusual gene will contribute to our
knowledge about the molecular basis of the functions of proteolytic
organelles and their relevance to hematopoietic cells. The proposal also
may lead to new insight about the regulation of a key transcriptional factor
that plays a significant role in many human diseases.
描述:(研究者摘要)蛋白质水解是一种基本的
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BING LIM其他文献
BING LIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BING LIM', 18)}}的其他基金
Development of a stem-cell derived thymic cell therapy to treat patients with athymia
开发干细胞衍生的胸腺细胞疗法来治疗无胸腺患者
- 批准号:
10609940 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Development of a stem-cell derived thymic cell therapy to treat patients with athymia
开发干细胞衍生的胸腺细胞疗法来治疗无胸腺患者
- 批准号:
10483294 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
相似海外基金
Harnessing combinatorial perception of BMP ligands to direct embryonic stem cell differentiation
利用 BMP 配体的组合感知来指导胚胎干细胞分化
- 批准号:
532674-2019 - 财政年份:2021
- 资助金额:
$ 27.21万 - 项目类别:
Postgraduate Scholarships - Doctoral
Defining the Role of NF-kB During Embryonic Stem Cell Differentiation
定义 NF-kB 在胚胎干细胞分化过程中的作用
- 批准号:
2599454 - 财政年份:2021
- 资助金额:
$ 27.21万 - 项目类别:
Studentship
Harnessing combinatorial perception of BMP ligands to direct embryonic stem cell differentiation
利用 BMP 配体的组合感知来指导胚胎干细胞分化
- 批准号:
532674-2019 - 财政年份:2020
- 资助金额:
$ 27.21万 - 项目类别:
Postgraduate Scholarships - Doctoral
Evaluation of market opportunities for a 'gastruloid' approach to three dimensional embryonic stem cell differentiation.
评估三维胚胎干细胞分化的“类原肠胚”方法的市场机会。
- 批准号:
BB/S02073X/1 - 财政年份:2019
- 资助金额:
$ 27.21万 - 项目类别:
Research Grant
Exploring the role and implications of a Histone Deacetylase III (HDAC3) and NCOR/SMRT in cancer and embryonic stem cell differentiation
探索组蛋白脱乙酰酶 III (HDAC3) 和 NCOR/SMRT 在癌症和胚胎干细胞分化中的作用和影响
- 批准号:
2264698 - 财政年份:2019
- 资助金额:
$ 27.21万 - 项目类别:
Studentship
Harnessing combinatorial perception of BMP ligands to direct embryonic stem cell differentiation
利用 BMP 配体的组合感知来指导胚胎干细胞分化
- 批准号:
532674-2019 - 财政年份:2019
- 资助金额:
$ 27.21万 - 项目类别:
Postgraduate Scholarships - Doctoral
Establishment of pediatric solid tumor development model using human embryonic stem cell differentiation induction system
利用人胚胎干细胞分化诱导系统建立小儿实体瘤发育模型
- 批准号:
15K09651 - 财政年份:2015
- 资助金额:
$ 27.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Embryonic stem cell differentiation: A key to unraveling the cellular mechanisms of patterning
胚胎干细胞分化:揭示细胞模式形成机制的关键
- 批准号:
272597766 - 财政年份:2015
- 资助金额:
$ 27.21万 - 项目类别:
Research Fellowships
How are enhancers activated during early embryonic stem cell differentiation
早期胚胎干细胞分化过程中增强子如何被激活
- 批准号:
BB/M006301/1 - 财政年份:2015
- 资助金额:
$ 27.21万 - 项目类别:
Research Grant
Long non coding RANs regulate the cardiac lineage during embryonic stem cell differentiation
长非编码 RAN 在胚胎干细胞分化过程中调节心脏谱系
- 批准号:
25860621 - 财政年份:2013
- 资助金额:
$ 27.21万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




